Markets:

Overview

News

Currencies

International

Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

52.37 +0.76 (+1.47%)

Streaming Delayed Price Updated: 11:23 AM EST, Dec 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novo Nordisk A/S Common Stock

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

99 100 Next >

GoodRx Holdings Surges 5% After Hours on Novo Nordisk Partnership for $499 Monthly Ozempic, Wegovy Access ↗

August 19, 2025

GoodRx stock rose 5.08% after it partnered with Novo Nordisk to offer Ozempic and Wegovy at a flat $499 monthly price for self-paying patients.

Via Benzinga

Insiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift4 ↗

August 18, 2025

A chip stock that recently partnered with NVIDIA. Now, a key company insider is buying over $160 million in shares, a bullish signal to investors.

Via MarketBeat

Topics Artificial Intelligence

Autonomous Vehicles Hit an Inflection Point; GPT-5 Is Here ↗

August 18, 2025

Motley Fool Money checks in on some stock market news.

Via The Motley Fool

Topics Economy

Why Weight-Loss Drugmaker Novo Nordisk’s Stock Is Rising Premarket Today ↗

August 18, 2025

Via Stocktwits

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 18, 2025

Via Benzinga

Stocks Muted Ahead Trump-Zelenskyy Meeting, First Solar Jumps: What's Moving Markets Monday? ↗

August 18, 2025

Investor risk sentiment paused at the start of the week, as markets awaited details expected to emerge later when President Donald Trump meets with Ukrainian President Volodymyr Zelenskyy and European...

Via Benzinga

Topics Government

Dayforce, Applied Digital, GoodRx, First Solar, TeraWulf: Stocks Making The Biggest Moves Today ↗

August 18, 2025

Dayforce shares skyrocketed 26% in Monday’s midday trade after reports suggested that private equity firm Thoma Bravo is in talks to acquire the human resources firm.

Via Stocktwits

Topics Artificial Intelligence ETFs Economy

Novo Nordisk Surges On Wegovy Win, Eyes Bullish Rebound Near 52-Week Lows ↗

August 18, 2025

Novo Nordisk is showing signs that a comeback might be on the horizon after it hit the lows of its 52-week trading range.

Via Benzinga

Ozempic And Wegovy Now Available Through GoodRx At Reduced Self-Pay Price, Stock Skyrockets ↗

August 18, 2025

GoodRx and Novo Nordisk launch a $499 monthly self-pay option for Ozempic and Wegovy, expanding access at 70,000 pharmacies across the U.S.

Via Benzinga

Market Movers: UnitedHealth, Intel, and Novo Nordisk Among Top Performers Reshaping the Financial Landscape

August 18, 2025

The financial markets are abuzz with significant movements across various sectors, driven by a confluence of strategic investments, groundbreaking regulatory approvals, and the enduring influence of...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Why Novo Nordisk Stock Popped Monday ↗

August 18, 2025

Novo Nordisk stock looks so cheap, any good news at all can make it pop.

Via The Motley Fool

Novo Nordisk Stock Surges After Pharma Major Cuts Ozempic Cost to $499 Per Month For Self-Paying Patients ↗

August 18, 2025

The new offer aims to assist Type 2 diabetes patients who are uninsured or choose to self-pay, and may potentially face prices at or above wholesale cost.

Via Stocktwits

Novo Nordisk Pops On A New Wegovy Approval, Dragging Hard On Madrigal Pharma ↗

August 18, 2025

The FDA will allow patients with MASH to undergo Wegovy treatment, hampering the only other company with an approved MASH drug.

Via Investor's Business Daily

Shareholders That Lost Money on Novo Nordisk A/S (NVO) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

August 18, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Shareholders That Lost Money on Novo Nordisk A/S (NVO) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

August 18, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Novo Nordisk A/S (NYSE: NVO)

August 18, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

Dow Futures Decline After Recent Rally, All Eyes On Powell’s Jackson Hole Speech: NVO, UNH, FSLR, RUN, PANW Among Stocks To Watch ↗

August 18, 2025

Via Stocktwits

Topics Stocks

Novo Nordisk's Wegovy Snags Conditional FDA Nod For Fatty Liver Disease ↗

August 18, 2025

FDA approves Novo Nordisk's Wegovy for MASH with liver fibrosis, supported by ESSENCE trial data as the company projects lower 2025 sales growth.

Via Benzinga

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO

August 17, 2025

From Pomerantz LLP

Via GlobeNewswire

1 Stock Down 40% This Year to Buy and Hold ↗

August 17, 2025

This might be a wonderful entry point for long-term investors.

Via The Motley Fool

This Healthcare Stock's Bad News Could Create a $10 Billion Opportunity for Competitors ↗

August 17, 2025

The drugmaker's recent dip could also be a buying opportunity.

Via The Motley Fool

Bragar Eagel & Squire, P.C. Reminds Investors of Novo, Altimmune, SelectQuote, and Spectrum that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm

August 16, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet. ↗

August 16, 2025

Viking Therapeutics' dual-formulation obesity drug could be the David to Lilly's Goliath.

Via The Motley Fool

Topics Economy

Why Novo Nordisk Flew Almost 3% Higher on Friday ↗

August 15, 2025

It seems to be holding off on price adjustments demanded by President Trump.

Via The Motley Fool

Topics Government

Levi & Korsinsky Reminds Novo Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 30, 2025 - NVO

August 15, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Levi & Korsinsky Reminds Novo Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 30, 2025 - NVO

August 15, 2025

Via TheNewswire.com

Topics Fraud Lawsuit

Pfizer's Investigational Drug Flunks Late-Stage For Sickle Cell Disease ↗

August 15, 2025

Pfizer's Phase 3 trial of inclacumab in sickle cell disease misses its main goal but shows safety, with further updates on other drugs planned.

Via Benzinga

Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst ↗

August 15, 2025

Eli Lilly's pricing strategy for GLP-1 drugs is expected to have minimal margin impact, with BofA reaffirming a $900 price target.

Via Benzinga

This House of Representative Just Bought Up To $95K In Novo Nordisk Stock ↗

August 15, 2025

Via Benzinga

Eli Lilly Strikes $1.3 Billion Deal With Superluminal To Develop AI-Driven Obesity Drugs ↗

August 15, 2025

Eli Lilly and Co (NYSE: LLY) has entered into a $1.3 billion deal with Superluminal Medicines to develop small-molecule drugs through artificial intelligence (AI) to treat obesity and other...

Via Benzinga

Topics Artificial Intelligence

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Novo Nordisk A/S Common Stock (NY:NVO)

All News about Novo Nordisk A/S Common Stock

Starting at $3.75/week.

Subscribe Today